Technical Report | Published:

Cas9-based enrichment and single-molecule sequencing for precise characterization of genomic duplications

Abstract

The widespread use of genome-wide diagnostic screening methods has greatly increased the frequency with which incidental (but possibly pathogenic) copy number changes affecting single genes are detected. These findings require validation to allow appropriate clinical management. Deletion variants can usually be readily validated using a range of short-read next-generation sequencing (NGS) strategies, but the characterization of duplication variants at nucleotide resolution remains challenging. This presents diagnostic problems, since pathogenicity cannot generally be assessed without knowing the structure of the variant. We have used a novel Cas9 enrichment strategy, in combination with long-read single-molecule nanopore sequencing, to address this need. We describe the nucleotide-level resolution of two problematic cases, both of whom presented with neurodevelopmental problems and were initially investigated by array CGH. In the first case, an incidental 1.7-kb imbalance involving a partial duplication of VHL exon 3 was detected. This variant was inherited from the patient’s father, who had a history of renal cancer at 38 years. In the second case, an incidental ~200-kb de novo duplication that included DMD exons 30–44 was resolved. In both cases, the long-read data yielded sufficient information to enable Sanger sequencing to define the rearrangement breakpoints, and creation of breakpoint-spanning PCR assays suitable for testing of relatives. Our Cas9 enrichment and nanopore sequencing approach can be readily adopted by molecular diagnostic laboratories for cost-effective and rapid characterization of challenging duplication-containing alleles. We also anticipate that in future this method may prove useful for characterizing acquired translocations in tumor cells, and for precisely identifying transgene integration sites in mouse models.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Davies SC. Annual report of the Chief Medical Officer 2016, generation genome. London: Department of Health; 2017. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/631043/CMO_annual_report_generation_genome.pdf.

  2. 2.

    Ebbert MTW, Jensen TD, Jansen-West K, Sens JP, Reddy JS, Ridge PG, et al. Systematic analysis of dark and camouflaged genes: disease-relevant genes hiding in plain sight. Genome Biol. 2019;20:97. https://www.ncbi.nlm.nih.gov/pubmed/31104630.

  3. 3.

    van Dijk EL, Jaszczyszyn Y, Naquin D, Thermes C. The third revolution in sequencing technology. Trends Genet. 2018;34:666–81.

  4. 4.

    Gabrieli T, Sharim H, Fridman D, Arbib N, Michaeli Y, Ebenstein Y. Selective nanopore sequencing of human BRCA1 by Cas9-assisted targeting of chromosome segments (CATCH). Nucleic Acids Res. 2018;46:e87.

  5. 5.

    Lee J, Lim H, Jang H, Hwang B, Lee JH, Cho J, et al. CRISPR-Cap: multiplexed double-stranded DNA enrichment based on the CRISPR system. Nucleic Acids Res. 2019;47:e1.

  6. 6.

    Tsai YC, Greenberg D, Powell J, Höijer I, Ameur A, Strahl M., et al. Amplification-free, CRISPR-Cas9 targeted enrichment and SMRT sequencing of repeat-expansion disease causative genomic regions. 2017. https://www.biorxiv.org/content/10.1101/203919v1.

  7. 7.

    Hafford-Tear NJ, Tsai YC, Sadan AN, Sanchez-Pintado B, Zarouchlioti C, Maher GJ, et al. CRISPR/Cas9-targeted enrichment and long-read sequencing of the Fuchs endothelial corneal dystrophy-associated TCF4 triplet repeat. Genet Med. 2019. https://doi.org/10.1038/s41436-019-0453-x.

  8. 8.

    Heger M. UK Hospital Launches Nanopore Sequencing Huntington’s Dx as Reflex Test. San Francisco: GenomeWeb; 2019. https://www.genomeweb.com/sequencing/uk-hospital-launches-nanopore-sequencing-huntingtons-dx-reflex-test#.XLCmLy3MzOY.

  9. 9.

    Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17:10–2.

  10. 10.

    Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009;25:1754–60.

  11. 11.

    Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment/map format and SAMtools. Bioinformatics 2009;25:2078–9.

  12. 12.

    De Coster W, D’Hert S, Schultz DT, Cruts M, Van Broeckhoven C. NanoPack: visualizing and processing long-read sequencing data. Bioinformatics 2018;34:2666–9.

  13. 13.

    Li H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 2018;34:3094–100.

  14. 14.

    Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–6.

  15. 15.

    Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res. 2002;12:996–1006.

  16. 16.

    Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010;26:841–2.

  17. 17.

    Lauridsen MF, Koldby KM, Krogh LN, Graakjaer J, Jensen TD, Fagerberg C, et al. A non-pathogenic duplication of DMD exon 45-51, inserted in chromosome 17, in three Danish patients. Presented at the European Human Genetics Conference, Milan (2018). Poster number P10.20D. http://www.abstractsonline.com/pp8/#!/4652/presentation/2271.

  18. 18.

    Watson CM, Crinnion LA, Berry IR, Harrison SM, Lascelles C, Antanaviciute A, et al. Enhanced diagnostic yield in Meckel-Gruber and Joubert syndrome through exome sequencing supplemented with split-read mapping. BMC Med Genet. 2016;17:1.

  19. 19.

    Hayes JL, Tzika A, Thygesen H, Berri S, Wood HM, Hewitt S, et al. Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation. Genomics 2013;102:174–81.

  20. 20.

    Newman S, Hermetz KE, Weckselblatt B, Rudd MK. Next-generation sequencing of duplication CNVs reveals that most are tandem and some create fusion genes at breakpoints. Am J Hum Genet. 2015;96:208–20.

  21. 21.

    Watson CM, Crinnion LA, Tzika A, Mills A, Coates A, Pendlebury M, et al. Diagnostic whole genome sequencing and split-read mapping for nucleotide resolution breakpoint identification in CNTNAP2 deficiency syndrome. Am J Med Genet A. 2014;164A:2649–55.

  22. 22.

    Gilpatrick T, Lee I, Graham JE, Raimondeau E, Bowen R, Heron A, et al. Targeted nanopore sequencing with Cas9 for studies of methylation, structural variants and mutations. 2019. https://www.biorxiv.org/content/10.1101/604173v1.

  23. 23.

    Baird NA, Etter PD, Atwood TS, Currey MC, Shiver AL, Lewis ZA, et al. Rapid SNP discovery and genetic mapping using sequenced RAD markers. PLoS ONE 2008;3:e3376.

  24. 24.

    Jain M, Koren S, Miga KH, Quick J, Rand AC, Sasani TA, et al. Nanopore sequencing and assembly of a human genome with ultra-long reads. Nat Biotechnol. 2018;36:338–45.

Download references

Acknowledgements

We thank the staff at Oxford Nanopore Technologies, particularly James Graham, Etienne Raimondeau, and Andy Heron for insight into the use of Cas9 reagents, and provision of early access protocols.

Funding

This work was supported by a UK Medical Research Council grant awarded to DTB (MR/M009084/1).

Author information

Correspondence to Christopher M. Watson.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Reagents and volumes used for the duplication-spanning PCR assay

Thermocycling conditions for the duplication-spanning PCR assays

Summary read metrics for Illumina whole genome sequencing dataset

Supplementary Figure 1

Guide RNA sequences

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark
Fig. 1
Fig. 2
Fig. 3
Fig. 4